EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Factors influencing blood tumor marker concentrations in the absence of neoplasia

Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández, Oncology Biomarkers Section of the Catalan Association of Clinical Laboratory Science

Tumor Biology · 19.03.2024 · 46 (s1) · S35-S63

DOI: 10.3233/tub-220023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Tumor Biology, online erschienen am 14.01.2024. Verfasst von Jaume Trapé und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Catalonia, Spain. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Lung Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tumor markers (TMs) are a heterogeneous group of molecules used in the diagnosis, prognosis and follow-up of cancer patients. During neoplastic differentiation, cells can either directly synthesize or induce the synthesis of TMs, and the release of these molecules into the bloodstream allows their quantification in biological fluids. Although very small concentrations of TMs are usually present in the serum or plasma of healthy subjects, increased concentrations may also be found in the presence of benign diseases or due to technical interference, producing false positive results. MATERIAL AND METHODS AND RESULTS: Our review analyses the causes of false positives described between January 1970 to February 2023 for the TMs most frequently used in clinical practice: α-fetoprotein (AFP), β2-microglobulin (β2-M), cancer antigen 15-3 (CA 15-3), cancer antigen CA 19-9 (CA 19-9), cancer antigen CA 72-4 (CA 72-4), cancer antigen 125 (CA 125), carcinoembryonic antigen (CEA), chromogranin A (CgA), choriogonadotropin (hCG), cytokeratin 19 fragment (CYFRA 21-1), neuron-specific enolase (NSE), human epididymis protein 4 (HE4), serum HER2 (sHER2), squamous cell carcinoma antigen (SCCA), protein induced by vitamin K absence-II (PIVKA-II), Pro-gastrin-releasing peptide (Pro-GRP), prostate-specific antigen (PSA), Protein S-100 (S-100) and thyroglobulin (Tg). A total of 247 references were included. CONCLUSIONS: A better understanding of pathophysiological processes and other conditions that affect the concentration of TMs might improve the interpretation of results and their clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorLung NeoplasmsMaleHumansAntigens, NeoplasmKeratin-19Carcinoembryonic AntigenProstate-Specific AntigenPhosphopyruvate HydrataseCA-125 Antigen

Stichwörter der Autor:innen

Tumor markersabsence of neoplasiabenign diseasefalse positives

Substanzen

Biomarkers, Tumorantigen CYFRA21.1Antigens, NeoplasmKeratin-19Carcinoembryonic AntigenProstate-Specific AntigenPhosphopyruvate HydrataseCA-125 Antigen

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Althaia Xarxa Assistencial Universitària de Manresa, Manresa, Catalonia, Spain.
  • Tissue Repair and Regeneration Laboratory, Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central, Barcelona, Spain.
  • Faculty of Medicine, University of Vic - Central University of Catalonia, Vic, Spain.
  • Department of Biochemistry and Molecular Genetics - Hospital Clinic de Barcelona, Barcelona, Spain.
  • Laboratori d'Anàlisis Clíniques, CLILAB Diagnòstics, Vilafranca del Penedès, Spain.
  • Gastrointestinal Oncology, Endoscopy and Surgery Research Group, Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central, Barcelona, Spain.

Zitieren

APA

Trapé, J., Fernández-Galán, E., Auge, J. M., Carbonell-Prat, M., Filella, X., Miró-Cañís, S., González-Fernández, C., & Oncology Biomarkers Section of the Catalan Association of Clinical Laboratory Science (2024). Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology, 46(s1), S35-S63. https://doi.org/10.3233/tub-220023

Vancouver

Trapé J, Fernández-Galán E, Auge JM, Carbonell-Prat M, Filella X, Miró-Cañís S, et al. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology. 2024;46(s1):S35-S63. doi:10.3233/tub-220023

BibTeX
@article{Trap2024,
  author = {Trapé, Jaume and Fernández-Galán, Esther and Auge, Josep Maria and Carbonell-Prat, Marina and Filella, Xavier and Miró-Cañís, Sílvia and González-Fernández, Carolina and Oncology Biomarkers Section of the Catalan Association of Clinical Laboratory Science, Oncology Biomarkers Section of the Catalan Association of Clinical Laboratory Science},
  title = {Factors influencing blood tumor marker concentrations in the absence of neoplasia},
  journal = {Tumor Biology},
  year = {2024},
  volume = {46},
  number = {s1},
  pages = {S35--S63},
  doi = {10.3233/tub-220023}
}
Kostenlos starten →